These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6842342)

  • 21. [Basis of a therapeutic protocol of nephrotic syndrome with minimal glomerular lesions in adults (proceedings)].
    Meyrier A; Simon P
    J Urol Nephrol (Paris); 1978 Sep; 84(9):684. PubMed ID: 748598
    [No Abstract]   [Full Text] [Related]  

  • 22. [T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome].
    Späth M; Schollmeyer P
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1161-4. PubMed ID: 7656849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary corticosteroid-resistant nephrotic syndrome in pediatrics].
    Tuya CO; Muñoz M; Costa JA; Repetto HA
    Medicina (B Aires); 1984; 44(1):1-7. PubMed ID: 6535901
    [No Abstract]   [Full Text] [Related]  

  • 24. Yellow nails and minimal change nephrotic syndrome.
    Yáñez S; Val-Bernal JF; Fernández-Llaca H
    Nephron; 1999 Jun; 82(2):180-2. PubMed ID: 10364711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal growth of nephrotic children during long-term alternate-day prednisone therapy.
    Polito C; Oporto MR; Totino SF; La Manna A; Di Toro R
    Acta Paediatr Scand; 1986 Mar; 75(2):245-50. PubMed ID: 3962658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus statement on management of steroid sensitive nephrotic syndrome.
    Indian Pediatric Nephrology Group, Indian Academy of Pediatrics
    Indian Pediatr; 2001 Sep; 38(9):975-86. PubMed ID: 11568373
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of combined prednisone + fluvastatin on cholesterol and bilirubin in pediatric patients with minimal change nephropathy.
    Song M; Li A; Gong J; Yang D; Ma L; Zhou X; Yan Y; Xie Y
    Clin Ther; 2013 Mar; 35(3):286-93. PubMed ID: 23485078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes.
    Jao W; Pollak VE; Norris SH; Lewy P; Pirani CL
    Medicine (Baltimore); 1973 Sep; 52(5):445-68. PubMed ID: 4725964
    [No Abstract]   [Full Text] [Related]  

  • 29. The fate of children with nephrotic syndrome in the light of the author's material.
    Derulska D; Wojnarowski M
    Pol Med J; 1970; 9(6):1368-73. PubMed ID: 5505050
    [No Abstract]   [Full Text] [Related]  

  • 30. [The catamnesis of patients with the minimal change nephrotic syndrome--lipoid nephrosis].
    Papaian AV; Savenkova ND; Val'kovich EI
    Pediatriia; 1990; (9):19-23. PubMed ID: 2259595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nephrosis, corticosteroid therapy and varicella].
    Vajs D; Bjelica M; Pandza Z; Lovrić E
    Med Arh; 1974; 28(2):211-4. PubMed ID: 4846817
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrent nephrotic syndrome associated with Kimura's disease in a young non-Oriental male.
    Atar S; Oberman AS; Ben-Izhak O; Flatau E
    Nephron; 1994; 68(2):259-61. PubMed ID: 7830867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children.
    Tejani A; Suthanthiran M; Pomrantz A
    Nephron; 1991; 59(1):96-9. PubMed ID: 1944755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of levamisole in the treatment of primary nephrosis in children.
    Mongeau JG; Robitaille PO; Roy F
    Pediatr Nephrol; 1988 Oct; 2(4):398-401. PubMed ID: 3153050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
    Gilbert RD; Hulse E; Rigden S
    Pediatr Nephrol; 2006 Nov; 21(11):1698-700. PubMed ID: 16932900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
    Hofstra JM; Deegens JK; Wetzels JF
    Nephrol Dial Transplant; 2007 Jul; 22(7):2100-2. PubMed ID: 17389619
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmune thyroiditis and vitiligo in a child with minimal change nephrotic syndrome.
    Kuzmanovska DB; Shahpazova EM; Kocova MJ; Gruevska SJ; Petrushevska G
    Pediatr Nephrol; 2001 Dec; 16(12):1137-8. PubMed ID: 11793116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
    Shahane A; Khasnis A; Gota C
    J Clin Rheumatol; 2012 Jun; 18(4):199-202. PubMed ID: 22647855
    [No Abstract]   [Full Text] [Related]  

  • 39. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
    Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
    Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria.
    Jonkers IJ; Bruijn JA; Vleming LJ
    Am J Kidney Dis; 2004 Oct; 44(4):773-7. PubMed ID: 15384031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.